COVID-19 Vaccine and Pregnancy Outcomes, Valacyclovir for Alzheimer Disease, Abortion Access in Los Angeles, and more
JAMA Editors' Summary
00:00
Valacyclovir shows no benefit for early Alzheimer disease
Kirsten outlines the VALAD Phase 2 trial: valacyclovir failed to slow cognitive decline in HSV‑seropositive early Alzheimer patients.
Play episode from 01:58
Transcript
